Biased exon/intron distribution of cryptic and de novo 3′ splice sites

被引:48
作者
Královicová, J [1 ]
Christensen, MB [1 ]
Vorechovsky, I [1 ]
机构
[1] Univ Southampton, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England
关键词
D O I
10.1093/nar/gki811
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We compiled sequences of previously published aberrant 3' splice sites (3'ss) that were generated by mutations in human disease genes. Cryptic 3'ss, defined here as those resulting from a mutation of the 3'YAG consensus, were more frequent in exons than in introns. They clustered in similar to 20 nt region adjacent to authentic 3'ss, suggesting that their under-representation in introns is due to a depletion of AG dinucleotides in the polypyrimidine tract (PPT). In contrast, most aberrant 3'ss that were induced by mutations outside the 3'YAG consensus (designated 'de novo') were in introns. The activation of intronic de novo 3'ss was largely due to AG-creating mutations in the PPT. In contrast, exonic de novo 3'ss were more often induced by mutations improving the PPT, branchpoint sequence (BPS) or distant auxiliary signals, rather than by direct AG creation. The Shapiro-Senapathy matrix scores had a good prognostic value for cryptic, but not de novo 3'ss. Finally, AG-creating mutations in the PPT that produced aberrant 3'ss upstream of the predicted BPS in vivo shared a similar 'BPS-new AG' distance. Reduction of this distance and/or the strength of the new AG PPT in splicing reporter pre-mRNAs improved utilization of authentic 3'ss, suggesting that AG-creating mutations that are located closer to the BPS and are preceded by weaker PPT may result in less severe splicing defects.
引用
收藏
页码:4882 / 4898
页数:17
相关论文
共 194 条
[31]   ZAP-70 DEFICIENCY IN AN AUTOSOMAL RECESSIVE FORM OF SEVERE COMBINED IMMUNODEFICIENCY [J].
CHAN, AC ;
KADLECEK, TA ;
ELDER, ME ;
FILIPOVICH, AH ;
KUO, WL ;
IWASHIMA, M ;
PARSLOW, TG ;
WEISS, A .
SCIENCE, 1994, 264 (5165) :1599-1601
[32]   Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome [J].
Chavanas, S ;
Bodemer, C ;
Rochat, A ;
Hamel-Teillac, D ;
Ali, M ;
Irvine, AD ;
Bonafé, JL ;
Wilkinson, J ;
Taïeb, A ;
Barrandon, Y ;
Harper, JI ;
de Prost, Y ;
Hovnanian, A .
NATURE GENETICS, 2000, 25 (02) :141-142
[33]   Splicing modulation of integrin β4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing [J].
Chavanas, S ;
Gache, Y ;
Vailly, J ;
Kanitakis, J ;
Pulkkinen, L ;
Uitto, J ;
Ortonne, JP ;
Meneguzzi, G .
HUMAN MOLECULAR GENETICS, 1999, 8 (11) :2097-2105
[34]   Evidence for a linear search in bimolecular 3′ splice site AG selection [J].
Chen, SY ;
Anderson, K ;
Moore, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :593-598
[35]   Evidence that U5 snRNP recognizes the 3' splice site for catalytic step II in mammals [J].
Chiara, MD ;
Palandjian, L ;
Kramer, RF ;
Reed, R .
EMBO JOURNAL, 1997, 16 (15) :4746-4759
[36]  
CHIODO AA, 1992, J BIOL CHEM, V267, P6361
[37]   The RNA splicing factor hSlu7 is required for correct 3′ splice-site choice [J].
Chua, K ;
Reed, R .
NATURE, 1999, 402 (6758) :207-210
[38]   An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing [J].
Chua, K ;
Reed, R .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1509-1514
[39]  
CLADARAS C, 1987, J BIOL CHEM, V262, P2310
[40]   Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2 [J].
Claes, K ;
Poppe, B ;
Machackova, E ;
Coene, I ;
Foretova, L ;
De Paepe, A ;
Messiaen, L .
GENES CHROMOSOMES & CANCER, 2003, 37 (03) :314-320